ArticleMolecular pharmaceutics2026

Tuning the Structural Properties of a Single-Domain Antibody Scaffold for Improved Fibroblast Activation Protein Targeting.

Joseph P Gallant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.